Home > Healthcare > Pharmaceuticals > Vaccines > Cholera Vaccines Market

Cholera Vaccines Market Trends

  • Report ID: GMI10163
  • Published Date: Jul 2024
  • Report Format: PDF

Cholera Vaccines Market Trends

The growing government and organizations support & initiatives tend to propel the market growth by primarily facilitating mass vaccination campaigns particularly in high-risk areas to enhance the accessibility and distribution of cholera vaccines to address global needs. These collaborative efforts aimed to raise public awareness pertaining to the importance of cholera immunization, while also providing essential funding, technical assistance, and resources to enable the effective implementation of vaccination programs in underdeveloped areas, thereby driving the market demand.
 

  • For instance, in March 2023, the WHO and the United Nations Children’s Fund (UNICEF) in collaboration with health authorities, the Syria Immunization Group (SIG), and Gavi, the Vaccine Alliance, launched a cholera vaccination campaign in earthquake-affected areas of northwest Syria. The campaign administered 1.7 million doses of cholera vaccine to protect Syrians over the age of one. This collaborative effort aimed at addressing public health crises, providing preventive measures against cholera in disaster-stricken regions, thereby bolstering the market demand.
     

Moreover, increasing research funding, and strategic approaches by key players focusing on the development, production, and distribution of cholera vaccines to vulnerable populations explore significant market opportunities.
 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The cholera vaccines market size was valued at USD 89.4 million in 2023 and is estimated to grow at 8.4% CAGR from 2024 to 2032, due to the growing global burden of cholera outbreak.

The euvichol/euvichol-plus market size was USD 40.4 million in 2023 and will grow at 8.2% CAGR during 2024-2032, due to their effectiveness, ease of administration, and affordability.

Canada cholera vaccines market accounted for USD 19.3 million in 2023 and is anticipated to showcase considerable growth through 2032, attributed to a comprehensive healthcare system, proactive public health policies, and high vaccination coverage.

Bavarian Nordic A/S, Bharat Biotech, Biological E, EuBiologics Co. Ltd, Hilleman Laboratories, Incepta Pharmaceuticals Ltd., Shantha Biotechnics (Sanofi), Vabiotech, and Valneva Sweden AB among others.

Cholera Vaccines Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 9
  • Tables & Figures: 311
  • Countries covered: 24
  • Pages: 160
 Download Free Sample